Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
EMHJ-Eastern Mediterranean Health Journal. 2006; 12 (5): 548-554
in English | IMEMR | ID: emr-156910

ABSTRACT

We examined the therapeutic effects of albendazole compared to metronidazole in 120 patients with giardiasis in Hamdan. Patients were randomized to receive albendazole [400 mg, once daily for 5 days] or metronidazole [250 mg, 3 times a day for 5 days]. Demographic data of the patients, results of stool for Giardia trophozoites before and after treatment, and drug side- effects were recorded. After treatment 6 [10.0%] of the albendazole group had trophozoites compared with 14 [23.3%] of metronidazole group [P < 0.05]. Patients in the albendazole group had fewer side- effects while 43.3% of the metronidazole group experienced a metallic taste and 35.0% experienced loss of appetite. Albendazole is an easy, safe and effective treatment for giardiasis


Subject(s)
Adolescent , Adult , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Feces/analysis , Feces/parasitology , Albendazole , Albendazole/adverse effects , Metronidazole/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL